Melatonin
-
Subject Areas on Research
- Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor.
- Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.
- Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid.
- Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins.
- Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin.
- Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice.
- Effect of MR imaging on the normal human pineal body: measurement of plasma melatonin levels.
- Effect of photoperiod on LH, FSH, prolactin and melatonin patterns in ovariectomized prepubertal heifers.
- Elevated serum melatonin is associated with the nocturnal worsening of asthma.
- Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.
- Involvement of the mt1 melatonin receptor in human breast cancer.
- Melatonin and agomelatine for preventing seasonal affective disorder.
- Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist.
- Melatonin increases both life span and tumor incidence in female CBA mice.
- Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
- Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells.
- Melatonin regulates energy balance and attenuates fever in Siberian hamsters.
- Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer.
- Melatonin: a chemical photoperiodic signal with clinical significance in humans.
- Neural and hormonal regulation of pancreatic secretion.
- Neuroendocrinology of melatonin in reproduction: recent developments.
- Novel melatonin-based treatments for major depression.
- Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice.
- Oxidative DNA damage during night shift work.
- Oxidative DNA damage during sleep periods among nightshift workers.
- Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings.
- Recognition and assessment of shift work disorder.
- Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid.
- Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
- Sensitivity of the human circadian system to short-wavelength (420-nm) light.
- Simultaneous quantification of urinary 6‑sulfatoxymelatonin and 8‑hydroxy‑2'‑deoxyguanosine using liquid chromatography-tandem mass spectrometry.
- Stressors and antistressors: how do they influence life span in HER-2/neu transgenic mice?
- The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice.
- The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep.
- Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy.
- Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin.
- Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system.
- Urinary 6-hydroxymelatonin in menstruating women.
- [Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM)]